MedTrace Logo

18F-FDG Tomography and Labeled Leukocyte Scintigraphy

NCT05994768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2023-11-30

No results posted yet for this study

Summary

The study will aim to show that there is a superiority of 18F-FDG PET/CT compared to labeled leukocyte scintigraphy in patients with a malignant otitis externa.

Conditions

  • Malignant Otitis Externa

Interventions

OTHER

18F-FDG PET/CT

Patients who underwent an 18F-FDG PET/CT examination and a labeled leukocyte scintigraphy before and after antibiotic therapy in the case of management of an EO.

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2023-07-12
Completion
2023-10-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05994768 on ClinicalTrials.gov